News
Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has included roflumilast (Daxas®) as a new treatment option in its COPD management guidelines. A section on the new class, phosphodiesterase 4 (PDE4) inhibitors, describes the efficacy of roflumilast in...
News
Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
Merck will hold its fourth-quarter 2010 sales and earnings conference call with institutional investors and analysts beginning at 8 a.m. EST on Thursday, Feb. 3. During the call, Kenneth C. Frazier, chief executive officer, Peter N. Kellogg, executive vice...
News
Teva Completes Acquisition of Theramex
Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of Theramex, Merck KGaA's European-based women's health business. Acquisition Provides Teva with a Strong Platform to Expand its Global Women's Health Franchise Theramex brings...
News
Novartis drug Tasigna received approval from the European Commission
Novartis received approval from the European Commission for Tasigna® (nilotinib) as a treatment for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The approval from the European Commission...
News
Arena and Eisai Complete End-of-Review Meeting with FDA
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA). Jack Lief, Arena's President and Chief Executive...
News
Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
H. Lundbeck A/S announced that it has signed agreements with Zenobia Therapeutics (Zenobia) and Vernalis plc (Vernalis) which will provide Lundbeck with access to know-how relevant for making inhibitors for Leucine-rich repeat kinases. Lundbeck will...
News
Merck Serono and San Raffaele Institute to Collaborate on Research
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced a strategic collaboration with the Institute of Experimental Neurology (INSpe) and the Department of Neurology of the San Raffaele Scientific Institute (Milan, Italy) to advance clinical research projects in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
